Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $1.5M (13,283 shares) of INSMED Inc on May 13, 2026. Filing
- Last sale before this period: Aug 18, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| INSMED Inc (INSM) | Chair and CEO, Director | Sep 12, 2012 | Jul 24, 2026 |
| NewAmsterdam Pharma Co N.V. (NAMS) | Director | Jan 8, 2024 | Jan 9, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 23, 2026, INSMED Inc: sold 10,700 shares for $1.1M, under a disclosed plan; 10,700 shares acquired by exercising options. 1 filing: 1
- Jul 9, 2026, INSMED Inc: sold 10,699 shares for $1.3M, under a disclosed plan; 10,699 shares acquired by exercising options. 1 filing: 1
- Jun 25, 2026, INSMED Inc: sold 21,398 shares for $2.2M, under a disclosed plan; 21,398 shares acquired by exercising options. 1 filing: 1
- Jun 8, 2026, INSMED Inc: sold 6,515 shares for $613K, under a disclosed plan. 1 filing: 1
- Jun 3, 2026, INSMED Inc: sold 7,605 shares for $778K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.